Blood test may predict nausea in breast cancer patients
NCT ID NCT07465172
First seen Mar 16, 2026 · Last updated May 13, 2026 · Updated 6 times
Summary
This study looks at whether a hormone called GDF-15, measured in the blood, can predict which breast cancer patients will experience severe nausea and vomiting from the drug T-DXd. Researchers will track 150 patients starting T-DXd treatment and compare their GDF-15 levels with side effects. The goal is to find a way to identify at-risk patients early, so doctors can better manage these side effects in the future.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Dana-Farber Cancer Institute
Boston, Massachusetts, 02215, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Lake Macquarie Private Hospital
Newcastle, New South Wales, 2290, Australia
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Okayama University Hospital
Okayama, 700-8558, Japan
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Peter MacCallum Cancer Centre
Melbourne, Victoria, 3000, Australia
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.